Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04989075
Other study ID # OP-PE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2022
Est. completion date July 25, 2023

Study information

Verified date February 2023
Source Claude Bernard University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pre-eclampsia (PE) remains a major source of maternal and perinatal morbidity and mortality especially in low- and middle-income settings. PE, a pregnancy-specific hypertensive disorder, characterized by the development of placental endothelial dysfunction resulting in, among the most common diagnostic features, concomitant hypertension and proteinuria that may evolve into organs with fluctuating clinical specificities. Current studies indicate that periodontal disorders during pregnancy and particularly periodontal pathogens may be related to the risk of PE. Standard oral hygiene methods, based mainly on the joint use of toothbrushes and interdental brushes, reduce periodontal inflammatory risk, modulate of the dysbiotic oral microbiome. The purpose of the present study is to compare the PE outcomes in high-risk pregnant women receiving oral prophylactic measures to a control group. One specific question is addressed as follows according to the PICO principles: In high-risk pregnant women (Population), does oral prophylactic measures (Intervention) have a beneficial effect on PE parameters (Outcome) compared to pregnant women without any specific oral prophylactic measures (Control)?


Recruitment information / eligibility

Status Completed
Enrollment 330
Est. completion date July 25, 2023
Est. primary completion date April 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - pregnant woman - women from sub-Saharan Africa - aged from 18 to 35 years old - nullipares at the time of the obstetrical consultation - up to 12 weeks pregnant - acceptance of the terms and conditions of the study - signature of the informed consent form, Exclusion Criteria: - fetal distress - congenital uterine and vaginal abnormalities - infectious or systemic diseases such as HIV, tuberculosis, candidiasis, cancers, hemopathies - premature termination of pregnancy for medical reasons - periodontal lesions of stage II, III (i.e., PD = 4 mm, and/or CAL = 4 mm), generalized (>30% of sites) - history or treatment of PD - a course of dental or orthodontic treatment - less than 20 natural teeth, excluding third molars - medication affecting the gum and/or oral mucosa - regularly using interdental brushes and/or dental floss and/or mouthwash - unable to answer questions or non-cooperative.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Oral prophylactic intervention
The oral prophylactic intervention will consist of the provision of specific package including a soft-bristled manual toothbrush, toothpaste, and a kit of calibrated interdental brushes (IDBs)(Curaprox CPS; Curaden) of sizes corresponding to the diameter of their interdental spaces. The participants will be instructed to brush their teeeth twice-daily and to realise a daily interdental brushing until delivery. The instructions for the use of the toothbrush and IDBs comprised verbal instructions supported by practical demonstration. The first use of the material will be conducted under the supervision of a qualified public health professor.

Locations

Country Name City State
Senegal Hospital Dakar

Sponsors (3)

Lead Sponsor Collaborator
Claude Bernard University Cheikh Anta Diop University, Senegal, University of Ouagadougou, Burkina Faso

Country where clinical trial is conducted

Senegal, 

References & Publications (1)

Gare J, Kanoute A, Meda N, Viennot S, Bourgeois D, Carrouel F. Periodontal Conditions and Pathogens Associated with Pre-Eclampsia: A Scoping Review. Int J Environ Res Public Health. 2021 Jul 5;18(13):7194. doi: 10.3390/ijerph18137194. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of pre-eclampsia from baseline during the pregnancy To determine if pregnant women suffer from pre-eclampsia, several indices are measured (diastolic or systolic pressure and proteinuria or urinary protein/creatinine ratio).
The combination of the results of pressure and proteinuria permits to classify of a woman as suffering from pre-eclampsia if:
the diastolic pressure is higher than 90 mm Hg on two 4 hours intervals, or > 110 mm Hg once, or systolic pressure > 140 mm Hg on two 4 hours intervals, or > 160 mm Hg once, after 20 weeks of gestation and,
the proteinuria measured is of 2+ or more, or > 300mg/24 hours, or > 500mg/L or urinary protein/creatinine ratio > 0.034g/mmol.
9 months of pregnancy
Secondary Number of pathogenic bacteria in the interdental microbiota during the pregnancy Quantitative PCR experiments will be performed and a quantitative analysis of the interdental microbiota will be made 3 months, 6 months and 8 months of pregnancy
Secondary Change of pocket probing depth of teeth during the pregnancy Quantification of the pocket probing depth of the teeth with a periodontal probe 3, 4, 5, 6, 7, 8 and 9 months of pregnancy
Secondary Change of clinical attachment level of teeth during the pregnancy Quantification of the clinical attachment level of the teeth with a periodontal probe 3, 4, 5, 6, 7, 8 and 9 months of pregnancy
Secondary Change of gingival index of teeth during the pregnancy Quantification of the gingival index 3, 4, 5, 6, 7, 8 and 9 months of pregnancy
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03249896 - Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes N/A
Completed NCT06338254 - Efficacy of Percussion Massage Therapy Applied to the Lower Extremity on Pain, Edema in Pregnant Women N/A
Recruiting NCT04825093 - Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19 N/A
Completed NCT04739462 - SMS Maama Project COVID-19 N/A
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Recruiting NCT03313024 - Berlin-Brandenburg Pregnancy Cohort
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06430853 - Psychobiological Interventions in Pregnancy N/A
Not yet recruiting NCT06357962 - Semi-permanent Acupuncture Effect on Cervical Ripening N/A
Not yet recruiting NCT03661749 - Urinary Protein to Creatinine Ratio in Term Pregnant Women N/A
Completed NCT02970721 - Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Completed NCT02191774 - Medical Abortion up to 10 Weeks Gestation at Home
Completed NCT01322529 - Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be N/A
Completed NCT00746551 - Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment Phase 4
Completed NCT00678080 - Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes N/A
Completed NCT00634530 - Impact of a Nutritional Intervention Program for Weight Control During Pregnancy N/A
Completed NCT00197561 - Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection Phase 3
Completed NCT05527327 - Pannus Retraction for Ultrasound Evaluation of the Obese Gravida: A Pilot Study N/A
Recruiting NCT05551078 - Thrombophilia Screening After Severe IUGR
Recruiting NCT03100084 - PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome

External Links